Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL

Clinical trial NCT01851551 · COMPLETED

Trial details

NCT number: NCT01851551
Sponsor: Acrotech Biopharma Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma Diffuse Large B-cell Lymphoma Mantle Cell Lymphoma

Start date: 2001-09-01
Primary completion: 2004-04-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.